Frontotemporale Lobärdegenerationen

J Diehl-Schmid; M Neumann; S M Laws; R Perneczky; T Grimmer; A Danek; A Kurz; M Riemenschneider; H Förstl

doi:10.1055/s-0028-1109107

Fortschritte der Neurologie · Psychiatrie, Table of Contents

Fortschr Neurol Psychiatr 2009; 77(5): 295-304
DOI: 10.1055/s-0028-1109107

Fort- und Weiterbildung

Frontotemporale Lobärdegenerationen

Teil 2: Bildgebung, Neuropathologie und GenetikFrontotemporal Lobar DegenerationPart 2: Neuroimaging, Neuropathology, NeurogeneticsJ. Diehl-Schmid¹ , M. Neumann¹ , S. M. Laws¹ , R. Perneczky¹ , T. Grimmer¹ , A. Danek¹ , A. Kurz¹ , M. Riemenschneider¹ , H. Förstl¹

¹Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München, Klinikum rechts der Isar

Abstract

Full Text

References

Literatur

1 Danek A, Diehl-Schmid J, Grimmer T. et al . Frontotemporale Lobärdegenerationen I. Diagnose und Therapie. Fortschr Neurol Psychiat. 2009; 77 169-179
2 Förstl H, Baldwin B. Pick und die fokalen Hirnatrophien. Fortschr Neurol Psychiat. 1994; 62 345-355
3 Schmitt H P, Yang Y, Förstl H. Frontal lobe degeneration of non-Alzheimer type and Pick’s atrophy – lumping or splitting. Europ Arch Psychiat Clin Neurosci. 1995; 245 299-305
4 Mendez M F, Shapira J S, McMurtray A. et al . Accuracy of the clinical evaluation for frontotemporal dementia. Arch Neurol. 2007; 64 830-835
5 Mosconi L, Tsui W H, Herholz K. et al . Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer’s Disease, and Other Dementias. J Nucl Med. 2008; 49 390-398
6 Foster N L, Heidebrink J L, Clark C M. et al . FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer’s disease. Brain. 2007; 130 2616-2635
7 Perneczky R, Diehl Schmid J, Förstl H. et al . Urinary incontinence and its functional anatomy in frontotemporal lobar degenerations. Europ J Nuclear Med Molecular Imaging. 2008; 35 605-610
8 Brambati S M, Renda N C, Rankin K P. et al . A tensor based morphometry study of longitudinal gray matter contraction in FTD. Neuroimage. 2007; 35 998-1003
9 Grimmer T, Diehl J, Drzezga A. et al . Region-specific decline of cerebral glucose metabolism in patients with frontotemporal dementia: a prospective F-18-FDG-study. Dementia Geriat Cogn Disord. 2004; 18 32-36
10 Diehl-Schmid J, Grimmer T, Drzezga A. et al . Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study. Neurobiol Aging. 2007; 28 42-50
11 Davies R R, Kipps C M, Mitchell J. et al . Progression in frontotemporal dementia: identifying a benign behavioral variant by magnetic resonance imaging. Arch Neurol. 2006; 63 1627-1631
12 Laws S M, Perneczky R R, Drzezga A. et al . Association of tau haplotype H 2 with age at onset and functional alterations of glucose utilization in frontotemporal dementia. Am J Psychiat. 2007; 164 1577-1584
13 Perneczky R, Diehl-Schmid J, Förstl H. et al . Male gender is associated with greater cerebral hypometabolism in frontotemporal dementia: evidence for sex-related cognitive reserve. Int J Geriat Psychiat. 2007; 22 1135-1140
14 Diehl-Schmid J, Grimmer T, Drzezga A. et al . Longitudinal changes of cerebral glucose metabolism in semantic dementia. Dement Geriatr Cogn Disord. 2006; 22 346-351
15 Diehl J, Grimmer T, Drzezga A. et al . Cerebral metabolic patterns at early stages of frontotemporal dementia and semantic dementia: a PET study. Neurobiol Aging. 2004; 25 1051-1056
16 Nestor P J, Graham N L, Fryer T D. et al . Progressive non-fluent aphasia is associated with hypometabolism centred on the left anterior insula. Brain. 2003; 126 2406-2418
17 Perneczky R, Diehl-Schmid J, Pohl C. et al . Non-fluent progressive aphasia: Cerebral metabolic patterns and brain reserve. Brain Res. 2007; 1133 178-185
18 Nestor P J, Balan K, Cheow H K. et al . Nuclear imaging can predict pathologic diagnosis in progressive nonfluent aphasia. Neurology. 2007; 68 238-239
19 Cairns N J, Bigio E H, Mackenzie I R. et al . Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol. 2007; 114 5-22
20 Neumann M, Sampathu D M, Kwong L K. et al . Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006; 314 130-133
21 Neumann M, Kwong L K, Sampathu D M. et al . TDP-43 Proteinopathy in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis: Protein Misfolding Diseases Without Amyloidosis. Arch Neurol. 2007; 64 1388-1394
22 Mackenzie I R, Foti D, Woulfe J. et al . Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions. Brain. 2008; 131 1282-1293
23 Hutton M, Lendon C L, Rizzu P. et al . Association of missense and 5’-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 1998; 393 702-705
24 Rademakers R, Cruts M, Broeckhoven van C. The role of tau (MAPT) in frontotemporal dementia and related tauopathies. Hum Mutat. 2004; 24 277-295
25 Laws S M, Friedrich P, Diehl-Schmid J. et al . Genetic analysis of MAPT haplotype diversity in frontotemporal dementia. Neurobiol Aging. 2008; 29 1276-1278
26 Baker M, Mackenzie I R, Pickering-Brown S M. et al . Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006; 442 916-919
27 Cruts M, Gijselinck I, Zee van der J. et al . Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature. 2006; 442 920-924
28 Pastor P, Ezquerra M, Perez J C. et al . Novel haplotypes in 17q21 are associated with progressive supranuclear palsy. Ann Neurol. 2004; 56 249-258
29 Pickering-Brown S M, Baker M, Gass J. et al . Mutations in progranulin explain atypical phenotypes with variants in MAPT. Brain. 2006; 129 3124-3126
30 Pittman A M, Myers A J, Abou-Sleiman P. et al . Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. J Med Genet. 2005; 42 837-846
31 Reed L A, Wszolek Z K, Hutton M. Phenotypic correlations in FTDP-17. Neurobiol Aging. 2001; 22 89-107
32 Skibinski G, Parkinson N J, Brown J M. et al . Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet. 2005; 37 806-808
33 Vance C, Al-Chalabi A, Ruddy D. et al . Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9 p13.2 – 21.3. Brain. 2006; 129 868-876
34 Watts G D, Thomasova D, Ramdeen S K. et al . Novel VCP mutations in inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia. Clin Genet. 2007; 72 420-426
35 Watts G D, Wymer J, Kovach M J. et al . Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet. 2004; 36 377-381
36 Schumacher A, Friedrich P, Diehl J. et al . No association of common VCP variants with sporadic frontotemporal dementia. Neurobiol Aging. epub; (angenommen)
37 Schumacher A, Friedrich P, Diehl-Schmid J. et al . No association of chromatin-modifying protein 2B with sporadic frontotemporal dementia. Neurobiol Aging. 2007; 28 1789-1790
38 Kabashi E, Valdmanis P N, Dion P. et al . TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet. 2008; 40 572-574
39 Sreedharan J, Blair I P, Tripathi V B. et al . TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008; 319 1668-1672
40 Van Deerlin V M, Leverenz J B, Bekris L M. et al . TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol. 2008; 7 409-416
41 Rollinson S, Snowden J S, Neary D. et al . TDP-43 gene analysis in frontotemporal lobar degeneration. Neurosci Lett. 2007; 419 1-4
42 Schumacher A, Friedrich P, Diehl-Schmid J. et al . No association of TDP-43 with sporadic frontotemporal dementia. Neurobiol Aging. 2009; 30 157-159
43 Benke T, Donnemiller E. The diagnosis of frontotemporal dementia. Fortschr Neurol Psychiat. 2002; 70 243-251
44 Diehl J, Monsch A U, Aebi C. et al . Frontotemporal dementia, semantic dementia, and Alzheimer’s disease: the contribution of standard neuropsychological tests to differential diagnosis. J Geriat Psychiat Neurol. 2005; 18 39-44
45 Bian H, Swieten J C, Leight van S. et al . CSF biomarkers in frontotemporal lobar degeneration with known pathology. Neurology. 2008; 70 1827-1835
46 Riemenschneider M, Wagenpfeil S, Diehl J. et al . Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration. Neurology. 2002; 58 1622-1628
47 Riemenschneider M, Diehl J, Müller U. et al . Apolipoprotein E polymorphism in German patients with frontotemporal degeneration. J Neurol Neurosurg Psychiat. 2002; 72 639-641
48 Besthorn C, Sattel H, Hentschel F. et al . Quantitative EEG in frontal lobe degeneration. J Neural Transm Suppl. 1996; 47 169-181
49 Lindau M, Jelic V, Johannson S E. et al . Quantitative EEG-abnormalities and cognitive dysfunctions in frontotemporal dementia and Alzheimer’s disease. Dementia Geriat Cog Disord. 2003; 15 106-114
50 Förstl H, Besthorn C, Hentschel F. et al . Frontal lobe degeneration and Alzheimer’s disease: a controlled study on clinical findings, volumetric brain changes and quantitative electroencephalography data. Dementia. 1996; 7 27-34
51 Förstl H. Neurodegenerative und verwandte Erkrankungen. Förstl H Frontalhirn – Funktionen und Erkrankungen Heidelberg; Springer 2005 2. Aufl: 144-175

Prof. Dr. Hans Förstl

Klinik und Poliklinik für Psychiatrie und Psychotherapie TU München Klinikum rechts der Isar

Ismaningerstr. 22

81675 München

Email: hans.foerstl@lrz.tu-muenchen.de